| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 2.0M +0.0% | 2.0M +0.0% | 2.0M +24.5% | 1.6M +1.4% | 1.6M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 2.0M +0.0% | 2.0M +0.0% | 2.0M +24.5% | 1.6M +1.4% | 1.6M |
| Operating Expenses | 13.8M +7.0% | 12.9M -15.6% | 15.2M +29.4% | 11.8M -1.3% | 11.9M |
| R&D | 1.2M -3.5% | 1.2M -3.7% | 1.3M +14.8% | 1.1M -8.9% | 1.2M |
| SG&A | 12.3M +6.5% | 11.5M +4.1% | 11.1M +9.7% | 10.1M +2.5% | 9.8M |
| Operating Income | -11802000 -8.3% | -10898000 +17.9% | -13267000 -30.1% | -10195000 +1.7% | -10375000 |
| EBITDA | -11501000 -6.5% | -10797000 -3.9% | -10388000 -7.9% | -9626000 -1.3% | -9507000 |
| Net Income | -4993000 -2180.4% | 240.0K -98.7% | 18.5M +380.6% | -6601000 -112.3% | 53.5M |
| EPS (Basic) | $-0.25 -2600.0% | $0.01 -99.0% | $0.99 +382.9% | $-0.35 -112.2% | $2.86 |
| EPS (Diluted) | $-0.25 -2600.0% | $0.01 -99.0% | $0.98 +380.0% | $-0.35 -112.2% | $2.86 |
| Shares (Diluted) | 19.6M -0.2% | 19.6M +3.7% | 18.9M +1.3% | 18.7M -0.1% | 18.7M |